Masimo (MASI) Share-based Compensation Growth (1y) (2010 - 2026)
Masimo (MASI) Share-based Compensation Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -30.44% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 59.09% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | -32.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -32.74% |
| Jan 3, 2026 | -253.45% |
| Sep 27, 2025 | 202.05% |
| Jun 28, 2025 | -95.42% |
| Mar 29, 2025 | 113.21% |
| Dec 28, 2024 | -31.76% |
| Sep 28, 2024 | -1,227.27% |
| Jun 29, 2024 | 214.18% |
| Mar 30, 2024 | -56.20% |
| Sep 30, 2023 | 60.71% |
| Jul 1, 2023 | -177.46% |
| Apr 1, 2023 | 11.01% |
| Apr 2, 2022 | -34.70% |
| Apr 3, 2021 | 1,072.12% |
| Sep 26, 2020 | 287.22% |
| Mar 28, 2020 | 1,057.72% |
| Jun 29, 2019 | 461.48% |
| Mar 30, 2019 | -97.69% |
| Jun 30, 2018 | -258.75% |
| Mar 31, 2018 | 84.56% |